Ascend Wellness Holdings (AAWH) Other Non Operating Income (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Other Non Operating Income of $121000.0 for Q1 2026, down 74.63% year-over-year from $477000.0 in Q1 2025, and down 35.98% quarter-over-quarter from $189000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Non Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $121000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 74.63% year-over-year to $121000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 29.86% YoY), while the FY2025 annual figure was $1.5 million, up 110.89% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $121000.0, down from $189000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $24.0 million in Q2 2023, with the low at -$391000.0 in Q4 2024.
- The 5-year median for Other Non Operating Income is $310000.0 (2024), against an average of $1.7 million.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income surged 15823.18% in 2023, then tumbled 161.87% in 2024.
- Ascend Wellness Holdings' Other Non Operating Income stood at $229000.0 in 2022, then surged by 175.98% to $632000.0 in 2023, then sank by 161.87% to -$391000.0 in 2024, then surged by 148.34% to $189000.0 in 2025, then sank by 35.98% to $121000.0 in 2026.
- Business Quant data shows AAWH's Other Non Operating Income at $121000.0 in Q1 2026, $189000.0 in Q4 2025, and $341000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ascend Wellness Holdings | 85.26 Mn | 18.26 Mn | 45.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 341,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | 477,000.00 |
| Dec 31, 2024 | -391,000.00 |
| Sep 30, 2024 | 409,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 24.04 Mn |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 273,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 44,000.00 |